Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
University Health Network, Toronto
University of Chicago
University of Maryland, Baltimore
Centre Antoine Lacassagne
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University of Virginia
Memorial Sloan Kettering Cancer Center
Sichuan University
Washington University School of Medicine
Roswell Park Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Zhejiang University
Fudan University
University of Florida
SCRI Development Innovations, LLC
Ludwig Institute for Cancer Research
University of Nebraska
University of Nebraska
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
The First Affiliated Hospital of Bengbu Medical University
Augusta University
Central European Society for Anticancer Drug Research
University of Texas Southwestern Medical Center
Abramson Cancer Center at Penn Medicine
Duke University
University of Maryland, Baltimore
University of California, San Diego
M.D. Anderson Cancer Center
University of Wisconsin, Madison
Oncology Institute of Southern Switzerland
Shiga University
Shenzhen People's Hospital
Maastricht Radiation Oncology
Columbia University
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Medical University of South Carolina
University of California, Davis
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Maastricht Radiation Oncology
University of Pittsburgh
Northwestern University
Virginia Commonwealth University
University of Southern California
AHS Cancer Control Alberta
Northwestern University
Rutgers, The State University of New Jersey